Azitra

Azitra Minority Interest

Minority Interest (Non-Controlling Interest) of Azitra (AZTR) as of Nov 5, 2026.

Minority Interest

-USD

Last updated:

Minority Interest (Non-Controlling Interest) of Azitra is 2026 - USD. Minority Interest (Non-Controlling Interest) of Azitra was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Azitra Stock analysis

What does Azitra do? Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees. Azitra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Azitra stock

On Eulerpool you can find the complete historical development of Minority Interest (Non-Controlling Interest) Azitra since 2006 – with annual values, charts, and detailed analysis.

Minority interest represents the portion of subsidiaries not owned by the parent company. It reflects third-party ownership stakes in consolidated entities.

Minority Interest (Non-Controlling Interest)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Minority Interest (Non-Controlling Interest)'s Azitra historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Azitra

All Key Metrics — Azitra